Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 22, 2025
Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema.
Journal: Clinical and translational science
Published: June 12, 2025
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors.
Journal: Clinical pharmacokinetics
Published: March 06, 2024
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective.
Journal: Expert review of clinical pharmacology
Published: June 07, 2023
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder.
Journal: Frontiers in neurology
Published: April 16, 2021
CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 19, 2020
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086.
Journal: Journal of pharmaceutical sciences
Published: January 10, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 02, 2018
Erratum to: Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling.
Journal: The AAPS journal
Published: January 18, 2017
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling.
Journal: The AAPS journal
Published: July 25, 2016
Mathematical modeling of receptor occupancy data: A valuable technology for biotherapeutic drug development.
Journal: Cytometry. Part B, Clinical cytometry
Published: January 28, 2015
Last Updated: 09/26/2026